QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Activity

11 hedge funds and large institutions have $500K invested in Qualigen Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
3
Calls
$3.71M
Puts
–
Net Calls
+$3.71M
Net Calls Change
+$1.16M

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$112K
2
VF
2
Virtu Financial
New York
$46K
3
Jane Street
3
Jane Street
New York
$13K
4
Creative Planning
4
Creative Planning
Kansas
$11K
5
UBS Group
5
UBS Group
Switzerland
$9K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
AC
2
Armistice Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$244K 279,999 – –
Renaissance Technologies
2
Renaissance Technologies
New York
$112K 128,418 +93,200 +265%
Vanguard Group
3
Vanguard Group
Pennsylvania
$49K 56,210 – –
VF
4
Virtu Financial
New York
$46K 52,426 +52,426 New
Jane Street
5
Jane Street
New York
$13K 14,687 +14,687 New
Creative Planning
6
Creative Planning
Kansas
$11K 12,060 +12,060 New
BlackRock
7
BlackRock
New York
$10K 11,731 +409 +4%
UBS Group
8
UBS Group
Switzerland
$9K 9,951 +5,411 +119%
CAM
9
CenterStar Asset Management
Illinois
– – – –
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$1K 1,200 – –
Wells Fargo
11
Wells Fargo
California
$1K 1,100 – –
SM
12
Sabby Management
Florida
– – -343,642 Closed
AC
13
Armistice Capital
New York
– – -50,771 Closed
Deutsche Bank
14
Deutsche Bank
Germany
– – -31 Closed
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$0 500 – –
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
– – – –
CFGS
17
Concourse Financial Group Securities
Alabama
– – – –